Drug-loaded nanocarriers in tumor targeted drug delivery

March 7, 2016
Drug-loaded nanocarriers in tumor targeted drug delivery
Nanoparticulate delivery systems in cancer therapies provide better penetration of therapeutic and diagnostic substances with the cancerous tissue in comparison to conventional cancer therapies. Credit: Dr. Buddolla Viswanath, Bentham Science Publishers

Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. It is a leading cause of death and the burden is expected to grow worldwide due to the growth and aging of the population, mainly in less developed countries, in which about 82% of the world's population resides. By 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths simply due to the growth and aging of the population. Current cancer therapy approaches are based in surgery, radiotherapy and chemotherapy, being the chemotherapy the one that shows the greater efficiency for cancer treatment, mainly in more advanced stages. A major problem with this conventional chemotherapy is its toxicity and it also destroys healthy tissues resulting in systemic toxicity besides beneficial characteristics of killing cancer cells. Anticancer drugs also destroy healthy tissues resulting in systemic toxicity.

A possible solution to avoid these adverse influences is targeted drug delivery, which is a safer mode of delivering the medication at the desired site of its action in increased concentrations compared to other sites for maximal beneficial effect. The extremely small size of nanoparticles makes it advantageous and potentially superior to use for targeted drug delivery. In addition, these nanoparticle platforms allow for selective targeting of cells or tumor vessels either by incorporating novel or standard anticancer drugs and/or the delivery of therapeutic genetic modulators.

The review article published in Current Biotechnology entitled "Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery" will allow to gain a more general view of the various drug loaded nanocarriers which offers a predominantly unique set of chemical, physical and photonic properties for better drug delivery to the tumor tissues based on morphological and functional differences between normal and tumor tissues.

Explore further: Researchers use nanoparticles to send chemotherapy drug directly to the tumor site

More information: Meerza Razak et al. Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery, Current Biotechnology (2015). DOI: 10.2174/2211550104666150525221950

Related Stories

Nano packages for anti-cancer drug delivery

March 18, 2015

Cancer stem cells are resistant to chemotherapy and consequently tend to remain in the body even after a course of treatment has finished, where they can often trigger cancer recurrence or metastasis. A new study by researchers ...

Study shows low-dose chemo keeps cancer under control

February 24, 2016

Rather than try to wipe out cancer with powerful doses of chemotherapy, researchers said Wednesday an experimental approach using lower amounts of medication may work better to keep tumors under control.

Recommended for you

Breakthrough in ultra-fast data processing at nanoscale

October 20, 2017

A research team from the National University of Singapore has recently invented a novel "converter" that can harness the speed and small size of plasmons for high frequency data processing and transmission in nanoelectronics.

Art advancing science at the nanoscale

October 18, 2017

Like many other scientists, Don Ingber, M.D., Ph.D., the Founding Director of the Wyss Institute, is concerned that non-scientists have become skeptical and even fearful of his field at a time when technology can offer solutions ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.